Lung Transplant Clinical Trial
Official title:
The Effect of Nutritional Status and Body Mass Index on Lung Capacity, Functional Capacity and Mortality in End-Stage Lung Patients on the Lung Transplant List
The aim of this study was to investigate the effect of nutritional risk index, BMI and body fat, muscle ratio on functional capacity, lung capacity, exercise capacity index, all-cause mortality, post-transplant intensive care unit stay and survival time in end-stage lung patients on the lung transplant list.
This study aimed to determine the nutritional status of patients awaiting lung transplantation and examine the effects of nutritional status, immunonutrition use, and BMI on lung capacity, mortality, and health status after lung transplantation. The study was designed in two different periods. The first period was a retrospective descriptive study. During this study, we will examine the retrospective nutritional status of patients who are waiting for lung transplantation, those who exited while on the list, or those who have received lung transplantation. In the second phase, we will conduct face-to-face interviews with patients on the lung transplant list, take bioelectrical impedance analyses (BIA), and record 24-hour food consumption to examine their detailed nutritional status. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05404919 -
Utilization of Hepatitis B Virus NAT+ Donors for Hepatitis B Vaccinated Lung Transplant Candidates
|
Phase 2 | |
| Completed |
NCT03299504 -
Factors Predicting Success in Lung Transplant Recipients Who Have Undergone Intensive Post-operative Rehabilitation
|
||
| Completed |
NCT00755781 -
Study of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung Transplantation
|
Phase 3 | |
| Recruiting |
NCT05547698 -
A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation
|
N/A | |
| Terminated |
NCT03207399 -
Lung Transplantation in Chronic HCV Infection With Post Transplant EPCLUSA Treatment
|
Phase 4 | |
| Completed |
NCT03300882 -
PREDICT Cytomegalovirus (CMV)
|
||
| Recruiting |
NCT05101460 -
An All Comers Registry For Normothermic Ex Vivo Lung Perfusion (EVLP) as Assessment of Donor Lungs for Transplant
|
||
| Completed |
NCT03150095 -
Health Coaching to Improve Self-Management in Thoracic Transplant Candidates
|
N/A | |
| Completed |
NCT04420195 -
Envarsus XR in Lung Transplant
|
Phase 2 | |
| Recruiting |
NCT02235610 -
Use of Ex Vivo Lung Perfusion (EVLP) in Reconditioning Marginal Donor Lungs for Transplantation
|
N/A | |
| Not yet recruiting |
NCT06066229 -
Identification of Patient Important Outcomes in Lung Transplantation
|
||
| Recruiting |
NCT04601818 -
Planned Semi-Elective Lung Tx Study
|
N/A | |
| Recruiting |
NCT03072589 -
Study to Evaluate Adenosine 2A Receptor Agonist (Regadenoson) in Patients Undergoing Lung Transplantation
|
Phase 1 | |
| Completed |
NCT01963780 -
International EXPAND Lung Pivotal Trial
|
N/A | |
| Recruiting |
NCT05671887 -
DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies
|
||
| Completed |
NCT03987113 -
Impact of Cold Ischemia on Pulmonary Endothelial Dysfunction in Ex-vivo Pulmonary Reconditioning
|
||
| Recruiting |
NCT02748798 -
Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders
|
Early Phase 1 | |
| Completed |
NCT03167528 -
Contribution of Learning and Practice of Different Complementary Therapies in Pulmonary Transplant Patients
|
N/A | |
| Active, not recruiting |
NCT04244734 -
Implementation of an Early Rehabilitation Program for the Patient With Lung Transplantation: From the ICU to Home.
|
N/A | |
| Active, not recruiting |
NCT01365429 -
Novel Lung Trial: Normothermic Ex Vivo Lung Perfusion (Evlp) As An Assessment Of Extended/Marginal Donor Lungs
|
N/A |